Increased risk and pattern of secondary malignancies in patients with invasive extramammary Paget disease

British Journal of Dermatology

Volumn 170, Issue 3, 2014, Pages 661-671

  Karam, A ^a   Dorigo, O ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANUS CANCER; ANUS DISEASE; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RISK; COLORECTAL CANCER; COLORECTAL DISEASE; DEMOGRAPHY; FEMALE; HIGH RISK PATIENT; HUMAN; INVASIVE EXTRAMAMMARY PAGET DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PAGET SKIN DISEASE; PRIORITY JOURNAL; SCROTUM CANCER; SCROTUM DISORDER; STANDARDIZED INCIDENCE RATIO; SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS PROGRAM; VULVA DISEASE; VULVAR CANCER; ANUS NEOPLASMS; COLORECTAL NEOPLASMS; GENITAL NEOPLASMS, MALE; INCIDENCE; NEOPLASMS, SECOND PRIMARY; PAGET DISEASE, EXTRAMAMMARY; PROGNOSIS; RISK FACTOR; SCROTUM; SKIN NEOPLASMS; TUMOR INVASION; VULVAR NEOPLASMS;

AGED; ANUS NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; GENITAL NEOPLASMS, MALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASMS, SECOND PRIMARY; PAGET DISEASE, EXTRAMAMMARY; PROGNOSIS; RISK FACTORS; SCROTUM; SKIN NEOPLASMS; VULVAR NEOPLASMS;

EID: 84896086428     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12635     Document Type: Article

References (36)

1. Chanda JJ,. Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol 1985; 13: 1009-14. (Pubitemid 16070114)
2. Fanning J, Lambert HC, Hale TM, et al,. Paget's disease of the vulva: prevalence of associated vulvar adenocarcinoma, invasive Paget's disease, and recurrence after surgical excision. Am J Obstet Gynecol 1999; 180 (1 Pt 1): 24-7. (Pubitemid 29088383)
3. Hashimoto T, Inamoto N, Nakamura K,. Triple extramammary Paget's disease. Immunohistochemical studies. Dermatologica 1986; 173: 174-9. (Pubitemid 16029489)
4. Lai YL, Yang WG, Tsay PK, et al,. Penoscrotal extramammary Paget's disease: a review of 33 cases in a 20-year experience. Plast Reconstr Surg 2003; 112: 1017-23.
5. McCarter MD, Quan SH, Busam K, et al,. Long-term outcome of perianal Paget's disease. Dis Colon Rectum 2003; 46: 612-16. (Pubitemid 36576417)
6. Pierie JP, Choudry U, Muzikansky A, et al,. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg 2003; 196: 45-50. (Pubitemid 36070993)
7. Nakano S, Narita R, Tabaru A, et al,. Bile duct cancer associated with extramammary Paget's disease. Am J Gastroenterol 1995; 90: 507-8.
8. Popiolek DA, Hajdu SI, Gal D,. Synchronous Paget's disease of the vulva and breast. Gynecol Oncol 1998; 71: 137-40. (Pubitemid 28492409)
9. Siesling S, Elferink MA, van Dijck JA, et al,. Epidemiology and treatment of extramammary Paget disease in the Netherlands. Eur J Surg Oncol 2007; 33: 951-5. (Pubitemid 47408729)
10. Kanitakis J,. Mammary and extramammary Paget's disease. J Eur Acad Dermatol Venereol 2007; 21: 581-90. (Pubitemid 46916755)
11. Sasaki M, Terada T, Nakanuma Y, et al,. Anorectal mucinous adenocarcinoma associated with latent perianal Paget's disease. Am J Gastroenterol 1990; 85: 199-202. (Pubitemid 20067087)
12. Wilkinson EJ, Brown HM,. Vulvar Paget disease of urothelial origin: a report of three cases and a proposed classification of vulvar Paget disease. Hum Pathol 2002; 33: 549-54. (Pubitemid 34747876)
13. Black D, Tornos C, Soslow RA, et al,. The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva. Gynecol Oncol 2007; 104: 547-50. (Pubitemid 46240244)
14. Karam A, Berek JS, Stenson A, et al,. HER-2/neu targeting for recurrent vulvar Paget's disease. A case report and literature review. Gynecol Oncol 2008; 111: 568-71.
15. Kodama S, Kaneko T, Saito M, et al,. A clinicopathologic study of 30 patients with Paget's disease of the vulva. Gynecol Oncol 1995; 56: 63-70.
16. Parker LP, Parker JR, Bodurka-Bevers D, et al,. Paget's disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 2000; 77: 183-9. (Pubitemid 30217323)
17. Howe HL, Wu X, Ries LAG, et al,. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006; 107: 1711-42. (Pubitemid 44582941)
18. Mariotto AB, Wesley MN, Cronin KA, et al,. Estimates of long-term survival for newly diagnosed cancer patients: a projection approach. Cancer 2006; 106: 2039-50. (Pubitemid 43673221)
19. Friedberg JW,. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma. Haematologica 2008; 93: 336-8. (Pubitemid 351398633)
20. Travis LB, Hill D, Dores GM, et al,. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst 2005; 97: 1428-37. (Pubitemid 41520078)
21. van der Zwan JM, Siesling S, Blokx WA, et al,. Invasive extramammary Paget's disease and the risk for secondary tumours in Europe. Eur J Surg Oncol 2012; 38: 214-21.
22. Surveillance, Epidemiology, and End Results (WWW document). National Cancer Institute Publication 12-4772 (March 2012). Available at: http://seer.cancer.gov/about/factsheets/SEER-brochure.pdf (accessed on 5 December 2013).
23. Hankey BF, Ries LA, Edwards BK,. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999; 8: 1117-21. (Pubitemid 30004912)
24. Hayat MJ, Howlader N, Reichman ME, Edwards BK,. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 2007; 12: 20-37. (Pubitemid 46143500)
25. Schoenberg BS, Myers MH,. Statistical methods for studying multiple primary malignant neoplasms. Cancer 1977; 40 (Suppl. 4): 1892-8. (Pubitemid 8216963)
26. Monson RR,. Analysis of relative survival and proportional mortality. Comput Biomed Res 1974; 7: 325-32.
27. Bradford PT, Freedman DM, Goldstein AM, Tucker MA,. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010; 146: 265-72.
28. Hutchison CL, Fritz AG, Roffers SD, (eds). Cancer Registry Management. Dubuque, IA: Kendall Hunt Publishing Company, 1997.
29. Neugut AI, Robinson E, Meadows AT,. Multiple Primary Cancers, 13th edn. Philadelphia: Lippincott Williams & Wilkins, 1999.
30. Berardi RS, Lee S, Chen HP,. Perianal extramammary Paget's disease. Surg Gynecol Obstet 1988; 167: 359-66. (Pubitemid 18262224)
31. Feuer GA, Shevchuk M, Calanog A,. Vulvar Paget's disease: the need to exclude an invasive lesion. Gynecol Oncol 1990; 38: 81-9. (Pubitemid 20206231)
32. Jones RR, Spaull J, Gusterson B,. The histogenesis of mammary and extramammary Paget's disease. Histopathology 1989; 14: 409-16. (Pubitemid 19129382)
33. Qian Y, Takeuchi S, Dugu L, et al,. Hematopoietic progenitor kinase 1, mitogen-activated protein/extracellular signal-related protein kinase kinase kinase 1, and phosphomitogen-activated protein kinase kinase 4 are overexpressed in extramammary Paget disease. Am J Dermatopathol 2011; 33: 681-6.
34. Niikura H, Yoshida H, Ito K, et al,. Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution. Int J Gynecol Cancer 2006; 16: 1212-15. (Pubitemid 43886748)
35. Smith RE,. Risk for the development of treatment-related acute myelocytic leukemia and myelodysplastic syndrome among patients with breast cancer: review of the literature and the National Surgical Adjuvant Breast and Bowel Project experience. Clin Breast Cancer 2003; 4: 273-9. (Pubitemid 37526972)
36. Du X, Freeman JL, Goodwin JS,. Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology and End Results. J Clin Epidemiol 1999; 52: 463-70. (Pubitemid 29305352)